Novavax, Inc.: Novavax Announces Approval of Nuvaxovid COVID-19 Vaccine for Primary and Booster Immunization in Japan : vimarsana.com

Nuvaxovid is the first protein-based COVID-19 vaccine approved for use in adults aged 18 and older in JapanApproval is first in the world for NVX-CoV2373 that includes both primary and booster

Related Keywords

Mexico , South Africa , Australia , Japan , Laura Keenan Lindsey , Erika Schultz , Stanleyc Erck , Ali Chartan , Linkedin , World Health Organization , European Commission , Drug Administration , Prnewswire Novavax Inc , Nasdaq , Exchange Commission , Administration Of Nuvaxovid , Japan Ministry Of Health , Novavax Inc , Japan Ministry , Nuvaxovid Intramuscular Injection , Chief Executive Officer , New Drug Application , Marketing Authorization Holder , Product Characteristics , Package Leaflet , New England Journal , World Health , Financial Condition , Novavax Annual Report , Keenan Lindsey , Novavax , Nnounces , Pproval , Nuvaxovid , Ovid , Accine , Rimary , Ooster , Mmunization ,